合肥拓锐生物科技有限公司是一家专业的新药开发,新药研发公司

Chinese | English

新药研发首页 > Patents Transfer > Patents Transfer projects
Patents Transfer projects
Ibandronate
2012-3-29
 

Ibandronate (sodium)

We provide skill&technology transfer of Ibandronate Injection / new plant building guidance ;We also provide these injection if you need finish product;

 

Ⅰ:Name:       Ibandronate Injection      (Bondronat)

Ⅱ:Formulations: Injection  Colorless and transparent liquid

Ⅲ:Specs:       1ml: 1mg   ;  2ml: 2mg   6ml:6mg   or  as  requirement;

Ⅳ:Indications:   Pathological Hypercalcemia induced by tumor  (abnormal).

Ⅴ:Dosage:  (1) Under the guidance of a doctor within hospital by intravenous injection.

(2) Patients shall adequate hydration with normal saline. Should also consider the severity of hypercalcemia and tumor type

(3) Severe hypercalcemia;4mg is enough (Serum calcium concentration≥3mmol/)

 Moderate hypercalcemia;4mg is enough (Serum calcium concentration≤3mmol/)

 

Ⅵ:      Features: As the bisphosphonates have high affinity for the inorganic ubstances in the  skeletion and bones; so ibandronate have a selective specificity of the bone;meanwhle,the bisphosphonates also inhibit osteoclast's activity.

Ⅶ:Areas export :    Africa

Middle East

Latin America

South East Asia

East Euro

Ⅷ:Production capacity  1000,000 pics /week

 

合肥网站建设 合肥网络推广 合肥seo优化 合肥网络营销 新药研发 药物研发 新药转让